| 02-Feb-2023 | S | Medico Remedies Limited has informed the Exchange that the Board of Directors at its meeting held on February 02, 2023, has considered and approved subdivision of 16596800 equity shares of 10 each into 82984000 equity shares of 2 each.
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of our Company at their meeting held today i.e. 2nd February, 2023 has, inter alia considered and approved the following: 1. Sub-division/ Stock Split of equity shares of the Company 2. Notice of Postal Ballot
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of our Company at their meeting held today i.e. 2nd February, 2023 has, inter alia considered and approved the following: 1. Sub-division/ Stock Split of equity shares of the Company
(As Per BSE Announcement Dated on 02.02.2023)
With reference to the above cited subject, we would like to inform to the exchange that Board of the Directors of the Company have fixed Thursday, 16th March, 2023 as the 'Record Date' for ascertaining eligibility of shareholders entitled for corporate action of - 1. Sub-division/split of 1 (One) equity shares of face value Rs. 10/- (Rupees Ten Only) each fully paid up into 5 (Five) equity shares of Rs. 2/- (Rupees Two Only) each fully paid up.
(As per BSE Announcement Dated on 04/03/2023)
Trading Members of the Exchange are hereby informed that MEDICO REMEDIES LIMITED, has fixed Record Date for the purpose of Sub-Division of the Equity Shares of the Company :-
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
MEDICO REMEDIES LIMITED
(540937)
RECORD DATE
16.03.2023
PURPOSE
Subdivision of the existing Equity Shares from One Equity Share of Rs.10/- each into Five Equity Shares of Rs.2/- each.
SUB-DIVIDED PAID-UP VALUE
Rs.2/-
SUB-DIVIDED PAID-UP VALUE W.E.F.
16/03/2023 DR-740/2022-2023
Note:-
i. ISIN No. INE630Y01016 of Rs. 10/- paid up will not be valid for transactions done on the Exchange on or after 16/03/2023.
ii. The new ISIN Number for Rs.2/- paid up will be informed to the market by a separate notice.
(As Per BSE Notice Dated on 08.03.2023)
This is in continuation to our communication dated 04th March, 2023 with respect to Sub-Division of Equity Share fully paid up with effect from March 16, 2023(Record Date). Please be informed that the Sub- Division of Equity Shares will take effect under the new ISIN i.e. INE630Y01024.
(As Per BSE Announcement dated on 10.03.2023)
In Continuation of Notice No. 20230308-21 dated March 08, 2023, Trading Members of the Exchange are hereby informed that the New ISIN number for the Sub-Divided Equity Shares of the Company will be as under: -
Company Name & Scrip Code
MEDICO REMEDIES LIMITED
(540937)
New ISIN No.
INE630Y01024
Remarks
Sub-division of Equity Shares from Rs.10/- to Rs.2/-
The new ISIN number given above, for Equity Shares of Rs.2/- each of the Company shall be effective for trades done on and from the Ex-Date i.e. 16-03-2023 (DR-740/2022-2023)
(As Per BSE Notice Dated on 14.03.2023) | 16-Mar-2023 | |
| 10-Nov-2021 | B | 3:1 Bonus Issue of Equity Shares
Trading Members of the Exchange are hereby informed that, MEDICO REMEDIES LIMITED has fixed the record date for the purpose of Bonus Issue. The transactions in the equity shares of the company would be on an ex-bonus basis with effect from the under mentioned date:
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME
& CODE
MEDICO REMEDIES LIMITED
(540937)
RECORD DATE
17/11/2021
PURPOSE
Issue of 03 (Three) Bonus equity shares of Rs.10/- each for every 01 (One) existing equity share of Rs.10/- each held.
Ex-Bonus basis from Date & Sett. No.
16/11/2021
DR-157/2021-2022
Trading Members are requested to note the change in the market lot of MEDICO REMEDIES LIMITED (540937) pursuant to the Bonus Issue of equity shares as given below, which will be effective from Tuesday, November 16, 2021:
Scrip Code
540937
Scrip Name
MEDICO REMEDIES LIMITED
Current Market Lot
600
Revised Market Lot
1200
(As Per BSE Notice Dated on 15.11.2021) | 17-Nov-2021 | 3:1 |
| 21-Nov-2024 | BC | Shweta Harshit Mehta & PACs | 18-Nov-2024 | |
| 21-Nov-2024 | BC | Harshit Mehta HUF & PACs | 18-Nov-2024 | |
| 21-Nov-2024 | BC | Rita Haresh Mehta & PACs | 18-Nov-2024 | |
| 06-Nov-2024 | BC | Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve Unaudited Financial Results for the quarter | 12-Nov-2024 | |
| 12-Nov-2024 | BC | Outcome of Board Meeting held today
Please find attached Outcome of Board Meeting held today
Please find attached Outcome of Board meeting held today | 12-Nov-2024 | |
No Dividends has been declared by MEDICO
Record Date17-Nov-2021
Ex-Bonus Date16-Nov-2021
Ratio3:1
Record Date16-Mar-2023
Split Date16-Mar-2023
Face Value (Before/After)10/2
RightsNo Rights has been declared by MEDICO
Book Closure
| 18-Nov-2024 | - | Shweta Harshit Mehta & PACs |
| 18-Nov-2024 | - | Harshit Mehta HUF & PACs |
| 18-Nov-2024 | - | Rita Haresh Mehta & PACs |
| 12-Nov-2024 | - | Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve Unaudited Financial Results for the quarter |
| 12-Nov-2024 | - | Outcome of Board Meeting held today
Please find attached Outcome of Board Meeting held today
Please find attached Outcome of Board meeting held today |